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Summary 
37 patients were treated upon carcinoma of the anal canal or anal margin between 1977 
and 1989. Although combined radiochemotherapy is of increasing interest as the treatment of 
choice our patients who underwent radical surgery in form of abdominoperineal rectum resec-
tion only had a very good outcome. Combined multimodal therapy by radiation and chemo-
therapy may possibly be able to reduce the rate of necessarv resections. Difficulties in finding 
out a relapse of disease after such treatments are discussed. The own experience with com-
bined radio-chemotherapy is not large enough at the present time to make significant state-
ments. Long term results have to be expected yet. Abdominop巴rinealrectum resection as a 
means of radical surgery stil has its place in the spectrum therapeutic modalities of treating 
anal carcinom日．
Introduction 
Due to the very rare occurence of the anal cancer which comprises about 2 percent of al 
colorectal carcinoma2l, there are no standardized methods of treatment5l The opinions about 
the best therapeutical concept differ very much according to literature. In addition to that the 
malignant anal cancer occurs in a multitude of different histological types. This is conditioned 
by the anatomic and functional structure of the sphincter ani and the history of development 
of the anal canal, which is a survival of the embryonic cloaca with the transitional zone of 
ectoderm and entoderm7•1丸山
Recent reports describe an improvement of the results of treatment by a combination of 
operation, radiation and chemotherapy1ム4,6,910,1, 12) 
Therefore we examined our own clinical cases treated in the above mentioned manner且nd
we compared our response with the literature. 
一一ー 一ー一一一←ー一一一一→
Key words: Anal 印刷叩同 Differentforms of treatm~~ of abdomino, Perin出町tumresection. 
索引語；Analcarcinoma, Different forms of treatment, Value of abdomino, Perinea! rectum resection. 




Within almost 12 years from March 1977 to January 1989 we treated 37 patients at the 
surgical department at Bonn University. The age ranged from 33 to 82 years with a mean 
age of 61, 2 years. 人JIpatients had a biopsy-proven cancer of the anal canal or anal margin. 
28 of these patients were found to suffer from epidermoid cancer, 6 from adenocarcinoma 
and 3 from cloacogenic carcinoma. As shown in Fig. 1 women over 60 years were percentually 
most afflicted. In accordance with the literature7) we found that the percentage of women 
who were afflicted by anal cancer was almost double as high (65~ぢ； n=24) as the disease 
occured in men (35%; n =13). 
Further we had a predominance of the anal canal cancer in women (92猪； n=22) but a 
predominance of the anal margin cancer in men (62~ぢ； n=8) (Fig.日）
35 out of a total amount of 37 patients could be followed up from 3 to 253 months after 
initial treatment. 
Due to the tumor stage we either performed the abdominoperineal rectum-amputation 
(APR) only (n = 12) or in combination with radiotherapy (n = 12). 7 patients were treated by 
local excision and radiation. 2 patients refused any further treatment after local excision. 
2 other patients are right now being tr四 tedby chemotherapy and radiation after the protocol 
initiated by NIGR010,w and its modification by DENECKE3•引. This combined cherno-
radiotherapy consists of two drugs: lV!itomyczn c (10 mg/m2) as an intravenous bolus injection 
on day 1, and 5-Fluorouracz'l (5-FU) (1000 mg/m2) as an intravenous infusion for 4 days (day 
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Fig. l. Age range of 37 patients with anal carcinoma. 
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Fig. 2. Sex ratio and localisation of the malignancy in 37 patients with anal cancer. 
Gy ( =200 rad) per day until a total dose of 40 Gァ（=4000 rad) has been reached. 
Restaging is done 3 weeks later and if the tumor is very small another irradiation of 20 
Gy ( =2000 rad) will take place. Should the tumor be stil large a radical APR is performed. 
This concenpt of treatment, i.e. the combined drug-radiation therapy is thought to increa~e 
the radio・sensitivenessof anal cancer. 
Results 
Sy閣がoms
The symptoms which made the patients consult the physician ranged from loss of weight, 
diarrhea and constipation, pruritus, palpable mass lesions, anal pain and rectal bleeding. 
Leading symptom was rectal bleeding in 65~ぢ（n=24) followed by anal pain in 43% (n = 16). 
Duration of symptoms ranged from 3 weeks to two years. 
Survival Rate and Moγtality 
The study group comprised 35 patients of which 71%25' were stil alive at the end of the 
this study. 345ぢ12'of the patients survived more than 5 years after treatment, 3796 (13 patients) 
were stil alive at the end of the study but have not reached the five-year-survival rate yet. 
A subdivision concerning the results of treatment in relation to the localization of the 
initial tumor shows, that in our series the cancer of the anal canal had an obviously better 
prognosis than the cancer of the anal margin (Fig.田）－
We further found that in our patients the cloacogenic cancer had the best chances of being 
cured whereas the adenocarcinoma had the worst (Fig. N). 
In general we saw the tendency that the patients, who were resistant to any treatment or 
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Fig. 3. Survival rate and mortality in general and as related to the various localisations 
of the anal cancer in 37 patients. 
had large lesions at the time of first examination died very soon (Fig. V ). This might be due 
to the variable aggressiveness and individual pathology as well as histological patterns of the 
different anal malignancies. 
Concerning the various possibilities of treatment in relation to the tumor localization there 
is none of the methods found to be clearly superior. In our collection of clinical cases we 
found 10 survivors out of 12 patients who underwent APR only. On the other hand 5 out of 
6 patients with local excision and radiation therapy survived (2 patients with anal canal cancer 
and 3 patients with anal margin cancer). 
Rel，咋sesand Metastases 
In our study we found relapse of anal cancer in 8 patients. One of these patients had 
his initial tumor at the anal margin and died meanwhile. The remaining 7 patients were 
suffering from anal canal tumors. 4 out of them are stil alive and 3 people already deceased. 
Metastases were found in 6 patients, 4 of these are not alive any more・
Discussion 
Due to the rarity of the anal carcinoma the various modes of treatment differ very much 
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Fig. 4. Survival rate and mortality in relation to the different histological entities. 
and range from APR and local excision to the different suggestions of radiotherapy only, and 
in addition to surgery as well as chemotherapy5•7•s,io,w 
On the one hand there is the attempt to preserve the anal sphincter but on the other hand 
there is a demand for the best possible and safest therapy concept in order to get the disease 
completely under control. 
The multimodal therapy with the addition of chemoradiation therapy as published by 
NIGR010•11•12i is expected to show better results of treatment than the radical surgery only. 
Recent reports show impressive shrinkage of the tumor. But it is not easy to recognize a 
persistant tumor after irradiation because although a scar might appear inconspicious, a 
malignant area can be overseen. A rather painstaking biopsy in an irradiated area might lead 
to the loss of function of the continence organ. Further there is no valid statement about 
lymph node metastasis formation by this biopsy. DENECKE reports about 6 out of 17 patients 
who underwent abdomino-perineal rectum-amputation after chemoradiation and who had re-
maining tumor residues3•4i He suggests the APR as the primary form of treatment at least 
for al tumors staged T 3 or T 4 by means of the T0JM-classification. 
With the exception of mucoepidermoid tumors and the microcellular malignoma the mor-
phology of the anal cancer is said to have litle influence on the prognosis only1•4•12•13i The 
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Fi邑.5. Survival rate of 37 patients with anal cancer atthe end of the study. 
is supposed to have a better prognosis than the anal canal cancer2•7> In contradiction to these 
literはLureresults we found 21 patients surviving after therapy of anal canal cancer, whereas 7 
of those patients died in our series. On the other hand only 4 out of 7 patients with disease 
of the anal margin survived. These results may however be produced by the comparatively 
small amount of patients with anal margin cancer in our experience. 
The anal cancer as an entity belongs to an autonomous system, the so called sphincter 
organ. This has to be taken into consideration while regarding the individual prognosis1伽．
Different from the rectal cancer with its main metastasis-distribution into the abdomen the 
anal cancer spreads its metastases into 3 main directions, especially into the groin. Because 
of this characteristic habit the anal malignancy has the worst rate of permanent cure compared 
to rectal carcinoma. If groin lymph nodes are affected most authors suggest the exstirpation 
of the lvmph nodes. Nevertheless the patients fate is infavourable. About 4 decades ago 
同veralattempts to prophylactic groin dissection were made. However, there was no advantage 
proven by this measureD. 
ト＇TELZNERhas advocated that the existance of either a slowmotion-cancer or quick-motion・ 
canceグ isimportant for the individual outcome of this malignant diseasern. This seems to be 
proven in our study group. Half of the 10 deceased patients died very fast within the first 6 
months after first diagnosis and treatment regardless to whatever kind of treatment was per・ 
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formed. The other half of the incurable patients however survived several years although they 
were suffering from advanced tumor stages. 3 of these 5 patients even died beyond the 5-
year“period. 
Based on different literature results combined chemoradiation therapy promises to increase 
the cure rate of anal cancer even in late tumor stages. The method should also be considered 
in case of recurrent disease and if the initial treatment was not consisiting of chemoradiotherapy. 
Due to the yet small number of cases and comparatively short follow-up time with that parti-
cular treatment in the own experience we cannot report significant statements about this thera-
peutical approach yet. However, chemoand radiotherapy are not free from a lot of unavoidable 
problems. 
Until there will be more experience with the long-term outcome of patients with chemo-
radiation therapy only w巴 wouldlike to emphasize the value of abdomino-perineal rectum 
resection in order to increase the rates of permanent cure as a strong therapeutical advice in 
the initial treatment for all infiltrating and recurrent anal cancers and for al remaining 
malignant lesions after non-surgical procedures. 
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